Same Indication

Escitalopram vs Nivolumab

Escitalopram vs Nivolumab: Overview

This comparison examines the pharmacological differences between Escitalopram and Nivolumab.

Mechanism of Action

Escitalopram: S-enantiomer of citalopram; selective serotonin reuptake inhibitor.

Nivolumab: Fully human anti-PD-1 IgG4 monoclonal antibody restoring T-cell anti-tumor activity.

Pharmacokinetics

Half-life: Escitalopram — 27-32 hours; Nivolumab — 27 days.

Chemical Properties

Molecular Formula: Escitalopram — C20H21FN2O.

Molecular Weight: Escitalopram — 324.3920 g/mol.

Type: Escitalopram — Small molecule; Nivolumab — Antibody.